Delivery Order SPE2DB20D3103-SPE2DB25FQ3M1
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,144.79 by the Defense Logistics Agency on June 18, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count). This is a firm fixed-price, competitive delivery order with no set-aside designation and an ultimate completion date of June 20, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of dextroamphetamine-amphetamine 15 mg capsules (100 count) with a ceiling value of $1,060.81. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure with an ultimate completion date of November 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on July 14, 2025, for the supply of Dextroamphetamine-Amphetamine 20 MG capsules (100-count packaging) with a ceiling value of $1,352.32. This firm fixed-price delivery order was issued through the Medical Supply Chain, a defense-focused federal agency supporting military healthcare procurement needs. The contract represents a competitively awarded, non-set-aside procurement without...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) valued at $1,381.44. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,804.17. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,014.76 for Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on October 29, 2025, with completion scheduled for October 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's broader federal pharmaceutical supply agreements. The place of performance is located in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count containers) with a ceiling value of $1,627.31. This is a firm fixed price delivery order with an ultimate completion date of November 28, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,931.64. This firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3M1Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) with a ceiling value of $1,091.56. This is a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and represents a non-competitive set-aside award. The contract will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for controlled substance medications reflects the company's established role as a critical vendor in the federal medical supply chain for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/17/25 |